Brief: Moberg Pharma Receives Patent Granted For Mob-015 In China

Moberg Pharma AB (publ)

23/11/2018 07:33

Nov 23 (Reuters) - Moberg Pharma AB (publ)  MBPH.ST :
    * PATENT GRANTED FOR MOB-015 IN CHINA
    * CHINESE PATENT OFFICE HAS ISSUED PATENT NO. 201280007874.9
FOR
MOB-015, VALID UNTIL 2032
    * ESTIMATES GLOBAL PEAK SALES POTENTIAL FOR MOB-015 TO BE IN
RANGE
OF USD 250-500 MILLION
    * IS ENTITLED TO MILESTONES OF USD 14.6 MILLION IN ADDITION
TO
ATTRACTIVE ROYALTIES ON NET SALES

Source text for Eikon:  ID:nWkr2XFxpS 
Further company coverage:  MBPH.ST 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))